DEXCOM INC (DXCM) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for DEXCOM INC (DXCM): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 65/100 — a percentile rank of DEXCOM INC’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $32.6B |
| P / E | 32.6× |
| P / S | 6.5× |
| EV / EBITDA | 23.3× |
| Gross margin | 62.5% |
| Operating margin | 22.9% |
| Net margin | 20.1% |
| Return on equity | 38.1% |
| ROIC | 32.2% |
| Revenue growth | 15.5% |
| Debt / equity | 0.5× |
| Dividend yield | 0.0% |
Is DEXCOM INC overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from DEXCOM INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact